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Abstract
High-throughput next-generation sequencing (NGS) technologies have evolved rapidly 
and are reshaping the scope of genomics research. The substantial decrease in the cost of 
NGS techniques in the past decade has led to its rapid adoption in biological research and 
drug development. Genomics studies of large populations are producing a huge amount 
of data, giving rise to computational issues around the storage, transfer, and analysis 
of the data. Fortunately, cloud computing has recently emerged as a viable option to 
quickly and easily acquire the computational resources for large-scale NGS data analy-
ses. Some cloud-based applications and resources have been developed specifically to 
address the computational challenges of working with very large volumes of data gener-
ated by NGS technology. In this chapter, we will review some cloud-based systems and 
solutions for NGS data analysis, discuss the practical hurdles and limitations in cloud 
computing, including data transfer and security, and share the lessons we learned from 
the implementation of Rainbow, a cloud-based tool for large-scale genome sequencing 
data analysis.
Keywords: next-generation sequencing, cloud computing, data analysis, workflow, 
pipeline
1. Introduction
High-throughput next-generation sequencing (NGS) technologies have evolved rapidly 
and are reshaping the scope of genomics research [1, 2] and drug development [3, 4]. The 
significant advances in NGS technologies, and consequently, the exponential expansion of 
biological data have created a huge gap between the computer capabilities and sequenc-
ing throughput [5, 6]. Technical improvements have greatly decreased the sequencing costs 
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and, as a result, the size and number of datasets generated by large sequencing centers have 
increased dramatically. The lower cost also made the sequencing data more affordable to 
small and midsize research groups. As always, digging out the “treasure” from NGS data is 
the primary challenge in bioinformatics, which places unprecedented demands on big data 
storage and analysis. It is becoming increasingly daunting for small laboratories or even large 
institutions to establish and maintain their own computational infrastructures for large-scale 
NGS data analysis.
A promising solution to address this computational challenge is cloud computing [7–10], 
where CPU, memory, and storage are accessible in the form of virtual machines (VMs). In 
recent years, cloud computing has spread very rapidly for the supply of IT resources (hard-
ware and software) of different nature, and is emerging as a viable option to quickly and eas-
ily acquire the computational resources for large-scale NGS data analyses. Cloud computing 
offers a wide selection of VMs with different hardware specifications and users can choose 
and configure these VMs to meet their computational demands. With the massive scale of 
users, cloud computing providers, such as Amazon, are continuously driving costs down, 
which in turn has led to the use of cloud computing for NGS data analyses attractive within 
the bioinformatics community. Despite the apparent benefits associated with cloud comput-
ing, there are also issues to be addressed. Data privacy and security are particularly important 
when managing sensitive data, such as the patients’ information from clinical genomics stud-
ies [11].
The aim of this chapter is to describe the application of cloud computing in large-scale NGS 
data analysis and to help scientists to understand advantages and disadvantages of cloud 
computing, and to make an informed-choice on whether to perform NGS analysis on cloud 
services or to build the infrastructure themselves. It is organized as follows. First, we give 
a brief introduction to NGS technology, including DNA sequencing, RNA sequencing, and 
ChIP-sequencing. Secondly, we briefly introduce cloud computing and its services. Thirdly, 
we summarize and review publicly available cloud-based NGS tools and systems, with some 
particular emphasis on “Rainbow” [12], a cloud-based tool for large-scale whole-genome 
sequencing. Finally, we will discuss the challenges and remaining problems related to the full 
adoption of cloud computing in the NGS data analysis.
2. Next-generation sequencing
Next-generation sequencing [13] platforms allow researchers to ask virtually any question 
related to the genome, transcriptome, or epigenome of any organism. It has already pro-
foundly changed the nature and scope of genomic research in the past few years. Sequencing 
methods differ primarily by how the DNA or RNA samples are obtained (e.g., organism, 
tissue type, normal vs. affected, experimental conditions) and by the data analysis options 
used. After the sequencing libraries are prepared, the actual sequencing processes are simi-
lar regardless of the method. There are a number of standard library preparation kits from 
different vendors that offer solutions for whole-genome sequencing (WGS), RNA sequenc-
ing (RNA-seq), targeted sequencing (such as exome sequencing, targeted RNA-seq or 16S 
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sequencing), and detection of DNA methylation and protein-DNA interactions. As the num-
ber of NGS methods is constantly growing, a brief overview covering the most common 
methods is presented below.
2.1. Genomics
A breakthrough in NGS in the last decade has provided an unprecedented opportunity to 
investigate the contribution of genetic variation to health and disease [14]. WGS and whole-
exome capture sequencing (WES) have emerged as compelling paradigms for routine clini-
cal diagnosis, genetic risk prediction, and rare diseases [15–18]. WGS of tumors [19] is an 
unbiased approach that provides extensive genomic information about a tumor at the single 
nucleotide level as well as structural variations such as large insertions, genomic rearrange-
ments, gross deletions, and duplications. Using low-coverage WGS of many individuals from 
diverse human populations, the 1000 Genomes Project [20] has characterized common varia-
tions and a considerable proportion of rare variations present in human genomes. With fall-
ing costs, it is now possible to sequence genomes of many individuals for association studies 
and other genomic analyses [21].
The WGS workflow is depicted in Figure 1. A human genome is fragmented into many short 
pieces that are sequenced by a sequencer. The sequencing step typically generates billions 
of short reads. All short reads are mapped to a reference genome, and genetic and struc-
tural variants can be identified with respect to the reference genome sequence. Human DNA 
is comprised of approximately 3 billion base pairs. 30× coverage sequencing of a personal 
Figure 1. WGS workflow. A human genome is fragmented and sequenced, and billions of short reads are generated by a 
sequencer. All short reads are aligned to the reference genome and genetic variants are identified accordingly.
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genome will produce approximately 100 gigabytes (GB) of nucleotide bases, and its corre-
sponding FASTQ file will be about 250 GB. For a WGS project consisting of 400 subjects, 100 
terabytes of disk space is required to store the raw reads alone. Additional space is required 
for storing intermediate files generated during data analyses. Transferring and processing a 
dataset of such size would be extremely time-consuming and heavily computation-intensive 
and thus they pose huge practical challenges in data analyses.
2.2. Transcriptomics
RNA sequencing (RNA-seq) has emerged as a powerful technology for transcriptome profil-
ing [22–25]. It allows both quantification of known or predefined RNA transcripts and the 
capability to detect and quantify rare and novel transcripts within a sample. Compared to 
microarray, RNA-seq has a broader dynamic range, which allows for the detection of more 
differentially expressed genes with higher fold-change [26]. It is also superior in detecting 
low abundance transcripts, differentiating biologically critical isoforms, and allowing the 
identification of genetic variants. Not only RNA-seq can detect underlying genomic altera-
tions at single-nucleotide resolution within expressed regions of the genome, but also it can 
quantify expression levels and capture variation not detected at the genomic level, includ-
ing the expression of alternative transcripts. In the past decade, RNA-seq has become one of 
the most versatile applications of NGS technology and has revolutionized the researches on 
transcriptome [27]. As in WGS, RNA-seq generates vast number of short reads that must be 
computationally aligned or assembled to quantify expression of hundreds of thousands of 
RNA transcripts. Similar to DNA sequencing, the enormous data from large-scale RNA-seq 
studies poses a fundamental challenge for data management and analysis in a local environ-
ment [28–30]. Consequently, limited access to computational infrastructure and high-quality 
bioinformatics tools, and the demand for personnel skilled in data analysis and interpreta-
tion, remains a serious bottleneck for most researchers.
2.3. Epigenomics and protein-DNA interactions
While genomics involves the study of heritable or acquired alterations in the DNA sequence, 
epigenetics is the study of heritable changes in gene activity caused by mechanisms other 
than DNA sequence changes [31, 32]. Mechanisms of epigenetic activity include DNA methyl-
ation, histone modification and more. A focus in epigenetics is the study of cytosine methyla-
tion (5-mC) states across specific areas of regulation such as promotors or heterochromatin. 
Cytosine methylation can significantly modify temporal and spatial gene expression and chro-
matin remodelling. Two methylation sequencing methods are widely used: whole-genome 
bisulfite sequencing (WGBS) and reduced representation bisulfite sequencing (RRBS). With 
WGBS-seq, sodium bisulfite chemistry converts nonmethylated cytosines to uracils, which 
are then converted to thymines in the sequence reads. In RRBS-seq, DNA is digested with 
MspI—a restriction enzyme unaffected by methylation status. Fragments in the 100–150 bp 
size range are isolated to enrich CpG and promotor containing DNA regions. Sequencing 
libraries are then constructed using the standard NGS protocols.
ChIP-sequencing, also known as ChIP-seq [33, 34], is a method used to analyze protein interac-
tions with DNA. ChIP-seq combines chromatin immunoprecipitation (ChIP) with massively 
parallel DNA sequencing to identify the binding sites of DNA-associated proteins. It can be 
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used for genome-wide mapping of transcription factor binding sites. Protein-DNA interac-
tions have a significant impact on many biological processes and disease states. The sequence 
reads generated by ChIP-seq are massive and need to be aligned to reference genome first, 
and then the locations of protein-DNA interactions are inferred based on enrichment of 
sequence reads along the genome.
3. Cloud computing
"Cloud Computing," by definition, refers to the on-demand delivery of IT resources and 
applications via the Internet with pay-as-you-go pricing. Cloud computing is a model for 
enabling ubiquitous, on-demand access to a shared pool of configurable computing resources 
(e.g., networks, servers, storage, applications, and services), which can be rapidly provisioned 
and released with minimal management effort. With cloud computing, you do not need to 
make large upfront investments in hardware and spend a lot of time on the heavy lifting of 
managing hardware. Instead, cloud computing providers such as Amazon Web Services own 
and maintain the network-connected hardware, and you can provision exactly the right type 
and size of computing resources you need. You can access as many resources as you need, 
almost instantly, and only pay for what you request and own. These computing resources 
include networks, servers, storage, applications, and services. There are several essential char-
acteristics of the cloud computing model.
a. Rapid elasticity: you only allocate resources when you need them, and you are able to 
dynamically scale-up and -down your allocated resources as your needs change over time.
b. Pay-as-you-go: you only pay when you consume computing resources, and only pay for 
how much you consume.
c. On-demand self-service: the user can request and manage the computing resources with-
out help from the service providers.
d. Cost-effective: classical computational infrastructure for data processing has become inef-
fective and difficult to easily scale-up and -down, and cloud computing is a viable and 
even a cheaper technology that enables large-scale data analysis.
Existing cloud-based services can be classified into four categories or layers (see Figure 2). 
The first one is Infrastructure as a Service (IaaS). This service model is offered in a comput-
ing infrastructure that includes servers (typically virtualized) with specific computational 
capability and/or storage. The user has full control on the operating system and applications 
that are deployed to, but with limited control, over the network settings. A good example 
is Amazon elastic compute cloud (EC2), which allows the user to request and manage vir-
tual machines, and Amazon simple storage service (S3), which allows storing and accessing 
data. The second category of service is Platform as a Service (PaaS) in which the provider 
offers the customer the authority to create applications using developing tools supported by 
the provider. PaaS features rapid application development and good scalability, presenting 
usefulness in developing specific applications for big biological data analysis. Typically, the 
environment delivered by PaaS includes programming language environments, web servers, 
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and databases. The Amazon Web Services (AWS) software development kit (AWS SDK) and 
Google App Engine are good examples of this service.
The third service is Software as a Service (SaaS). SaaS eliminates the need for local installation 
and eases software maintenances and updates, providing up-to-date cloud-based services for 
data analysis. Customers do not manage the cloud infrastructure or network components, 
servers, operating systems, or storage, and can use the applications provided by the cloud 
provider. Most bioinformatics applications are open-source projects, and difficult to build, 
configure and maintain, primarily because they lack good documentation and have com-
plex library dependencies. However, as all software applications are installed and config-
ured within the VM, SaaS provides the perfect solution. The fourth layer is Data as a Service 
(DaaS). Bioinformatics clouds are heavily dependent on data, as data are fundamentally cru-
cial for downstream analyses and knowledge discovery. Due to such unprecedented growth 
in biological data, delivering Data as a Service (DaaS) via the Internet is of utmost importance. 
DaaS enables dynamic data access and provides up-to-date data that are accessible by a wide 
range of devices that are connected over the web. AWS provides a centralized repository of 
public data sets, including GenBank [35], 1000 Genomes [20], encyclopedia of DNA elements 
[36], etc., and all public datasets are delivered as services in AWS and thus can be seamlessly 
integrated into cloud-based applications.
4. NGS data analysis on cloud computing
In recent years, cloud computing offers an alternative approach to quickly and easily acquire 
computational resources for large-scale NGS data analysis. As a result, many cloud-based 
services and bioinformatics platforms (see Table 1), applications (see Table 2), and resources 
have been developed to address the specific challenges of working with the large volumes of 
data generated by NGS technology. Cloud computing has created new possibilities to analyze 
NGS data at reasonable costs, especially for laboratories lacking a dedicated bioinformatics 
Figure 2. Illustration of cloud services [8]. Cloud-based services in are grouped into Data as a Service (DaaS), Software 
as a Service (SaaS), Platform as a Service (PaaS), and Infrastructure as a Service (IaaS).
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infrastructure. From the perspective of end users, there are three options to analyze NGS 
data on cloud computing (Tables 1 and 2). First, commercial systems such as DNAnexus 
and Seven Bridges can be used out of box to carry out the entire NGS data analysis. Second, 
commercial or open bioinformatics platforms are further customized to meet users’ compu-
tational needs. Third, open-source tools (Table 2) can be deployed into the cloud for any 
customized data analysis.
4.1. Commercial services
Commercial services provide the users with well-established pipelines, user interfaces, and 
even application programming interfaces (APIs), and can reduce the time and effort required 
for setting up pipelines for NGS data analysis. For instance, DNAnexus and Seven Bridges 
offer various customizable NGS data analysis pipelines. In addition, DNAnexus also pro-
vides software that can directly upload the sequencing data produced. BaseSpace, launched 
by Illumina in collaboration with Amazon, is a genomics cloud computing platform that pro-
vides NGS data analysis services, such as mapping, de novo assembling, small RNA analy-
sis, library quality control (QC), metagenomics analysis, and data storage. It is designed to 
bring simplified data management and analytical sequencing tools directly to researchers in a 
user-friendly manner. BaseSpace provides flexibility and convenience with an array of tools, 
significantly simplifying the process of yielding meaningful results from NGS data. Bina 
Technologies offers a service that is composed of a specialized hardware called Bina Box and 
a cloud service. Bina Box can employ accelerated BWA [54] and GATK [55] for data analyses.
Some commercial services also provide APIs with which the users can manage their jobs or 
build their own applications. Variant calling on datasets of hundreds or thousands of genomes 
is time-consuming, expensive, and not easily reproducible given the myriad components of a 
variant calling pipeline. To address these challenges, the Mercury [47] analysis pipeline was 
Name URL Description
BaseSpace http://basespace.illumina.com Commercial services
Bina http://www.bina.com/ Commercial services
DNAnexus http://www.dnanexus.com Commercial services
SevenBridges http://www.sbgenomics.com Commercial services
Eoulsan http://transcriptome.ens.fr/eoulsan Cloud-based platform
CloVR http://clovr.org Automated sequence analysis
Cloud BioLinux http://cloudbiolinux.org Virtual machine for bioinformatics cloud computing
CloudMan https://wiki.galaxyproject.org/CloudMan Cloud-scale Galaxy
Globus Genomics https://www.globus.org/genomics Cloud-based bioinformatics workflow for NGS 
analyses
GenomeCloud http://www.genome-cloud.com/ Analyze genome data
COSMOS http://cosmos.hms.harvard.edu/ Workflow management system
Table 1. Cloud computing services and platforms.
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developed on top of the DNAnexus platform. It integrates multiple sequence analysis com-
ponents across various computational steps, from obtaining patient samples to providing a 
fully annotated list of variant sites for clinical applications. Mercury is an automated, flexible, 
and extensible analysis workflow that provides accurate and reproducible genomic results at 
scales ranging from individuals to large cohorts.
Although a number of cloud-based pipelines are available for analyses of sequencing data in 
massively parallel DNA sequencing, the majority of them can only identify variants within a 
single sample. While this approach has enough power for detecting variants in high-coverage 
sequencing, it performs worse than multiple-sample calling when applied to low-coverage 
sequencing data. To this end, another scalable DNAnexus-based pipeline for joint variant call-
ing in large samples was developed and deployed to the Amazon cloud. Using this pipeline, 
Shringarpure et al. [21] identified 68.3 million variants in 2535 samples from Phase 3 of the 
1000 Genomes Project. By performing the variant calling in a parallel manner, the data was 
processed within 5 days at a compute cost of just $7.33 per sample (a total cost of $18,590 for 
completed jobs and $21,805 for all jobs).
Despite their merits, these commercial services also have several disadvantages. First, the use 
of a commercial service requires extra expenses for the convenience of NGS data analysis and 
user-friendly interfaces. Second, compared to open-source tools on the cloud, the commercial 
Software URL Description Reference
Atlas2 http://atlas2cloud.sourceforge.net Genome analysis [37]
CloudAligner http://cloudaligner.sourceforge.net Reads mapping [38]
CloudBurst http://cloudburst-bio.sourceforge.net Reads mapping [39]
Crossbow http://bowtie-bio.sourceforge.net/crossbow Read mapping/SNP call [40, 41]
FX http://fx.gmi.ac.kr RNA-seq [42]
Myrna http://bowtie-bio.sourceforge.net/myrna RNA-seq [43]
Stormbow http://s3.amazonaws.com/jnj_stormbow/index.html RNA-seq [44]
STORMSeq http://www.stormseq.org/ Read mapping [45]
GenomeKey https://github.com/LPM-HMS/GenomeKey Whole genome analysis [46]
Mercury https://www.hgsc.bcm.edu/software/mercury Workflow for genomic 
analysis
[47]
Rainbow http://s3.amazonaws.com/jnj_rainbow/index.html Whole genome analysis [12]
PaekRanger http://ranger.sourceforge.net ChIP-seq [48]
VAT http://vat.gersteinlab.org Variant annotation [49]
YunBe http://tinyurl.com/yunbedownload Gene set analysis [50]
BioVLAB-MMIA-NGS https://sites.google.com/site/biovlab/ microRNA-mRNA 
integrated analysis
[51, 52]
SURPI http://chiulab.ucsf.edu/surpi/ Pathogen identification [53]
Table 2. Open-source tools for cloud computing.
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services are less customizable with respect to the use of the services and access to the cloud 
service. Although DNAnexus and Seven Bridges provide APIs to access and control their 
cloud services, their functionalities are restricted and the users have to request the service 
provider to set up new application software on their cloud services.
4.2. Bioinformatics platforms
CloudBioLinux [56] is a publicly accessible virtual machine (VM) that is based on an Ubuntu 
Linux distribution and is available to all Amazon EC2 users for free. It comes with a user-
friendly graphical user interface (GUI), along with over 135 preinstalled bioinformatics 
packages. CloudBioLinux instances provide an excellent environment for users to become 
familiar with BioLinux and cloud computing. Galaxy is an open, web-based platform for 
data-intensive biomedical research. Whether on the free public server or your own instance, 
you can perform, reproduce, and share the entire data analyses. Galaxy Cloud [57], a cloud-
based Galaxy platform for the analysis of data at a large scale, is the most used platform 
for bioinformatics. Unlike commercial software service solutions, users can customize their 
deployment and have complete control over their instances and associated data. Currently, 
a public Galaxy Cloud deployment, called CloudMan [57], is provided on the AWS cloud, 
enables bioinformatics researchers to easily deploy, customize, and share their cloud analy-
sis environment, including data, tools, and configurations. By combining three platforms, 
CloudBioLinux, CloudMan, and Galaxy, into a cohesive unit, researchers can gain access to 
more than 135 preconfigured bioinformatics tools and gigabytes of reference genomes on top 
of the flexible cloud computing infrastructure [56].
Although Galaxy cloud provides a convenient platform for researchers, challenges remain 
in moving large amounts of data reliably and efficiently and in adding domain-specific tools 
for specific analyses. To address these challenges, Globus Genomics [58, 59] was developed 
at the Computation Institute (CI), a joint institute between the University of Chicago and 
Argonne National Laboratory. Globus Genomics is a cloud-based integrated solution for 
NGS data analysis. It extends the existing Galaxy workflow system by adding data manage-
ment capabilities for transferring large quantities of data efficiently and reliably (via Globus 
Transfer), domain-specific analyses tools preconfigured for immediate use by researchers (via 
user-specific tools integration), automatic deployment on cloud for on-demand resource allo-
cation and pay-as-you-go pricing (via Globus Provision), and a cloud provisioning tool for 
auto-scaling (via HTCondor scheduler). Genome sequencing is notoriously data-intensive, 
and Globus Transfer [59] is designed for fast and secure movement of large amounts of data. 
Setting up a production instance of Galaxy is a nontrivial task that involves a number of 
manual installation and configuration steps for both the platform and any dependent soft-
ware packages—steps that can be both error-prone and time-consuming. Globus Provision 
addresses the above issues by providing on-demand cluster reconfiguration, user-specific 
node provisioning, and automatic instance deployment on Amazon EC2.
GenomeCloud (http://www.genome-cloud.com/) is another on-demand Galaxy cloud. It was 
built upon Galaxy, and is composed of g-Analysis, g-Cluster, g-Storage, and g-Insight ser-
vices, providing convenient services to the researchers and other users. GenomeCloud is a 
complete and integrated platform for analyzing genome data to the interpretation of analysis 
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results. It combines the idea of cloud computing with bioinformatics to generate an integrated 
solution for data storage and sharing, database management, continuously updated comput-
ing and analysis tools, and security. GenomeCloud is designed to help researchers perform 
bioinformatics tasks more easily, as well as to support laboratories without the computational 
resources to conduct research without hurdles.
4.3. Open-source tools
The development of tools supporting NGS data analysis with cloud computing has recently 
become popular in the open-source community [8]. Currently, there are many pipelines and 
workflows that support cloud computing (Table 2). Despite their advantages in cost and 
flexibility, open-source tools on the cloud also have substantial drawbacks. The users are 
responsible for designing/setting up the entire analysis pipeline, the data management and 
hardware configuration, such as CPUs, memory, storage, and security. Quite often, the users 
have to overcome a laborious series of trial and error before setting up the proper configura-
tion. Although several tools have been developed to date, in most cases, their cloud comput-
ing support is incomplete and their functionality is under-developed. Here, we will briefly 
report some existing bioinformatics tools and then describe Rainbow, a cloud-based tool for 
large-scale WGS data analysis, in detail in the next section.
CloudAligner [38] and CloudBurst [39] are parallel read mapping algorithms optimized for 
mapping short reads to human and other reference genomes and can produce alignments for 
a variety of downstream biological analyses including SNP discovery, genotyping, and per-
sonal genomics. Crossbow is a Hadoop- [60] based tool that combines the speed of the short 
read aligner bowtie [61], with the accuracy of the SNP caller SOAPsnp [62] to perform align-
ment and SNP detection from WGS data in parallel. Scalable tools for open-source read map-
ping (STORMseq) [45] is a graphical interface cloud computing solution that performs read 
mapping, read cleaning, variant calling, and annotation using personal genome data. Variant 
annotation tool (VAT) [49] has been developed to annotate variants from multiple personal 
genomes at the transcript level as well as to obtain summary statistics across multiple genes 
and individuals.
FX [42] is an RNA-seq analysis tool, which runs in parallel on cloud computing infrastruc-
ture, for the estimation of gene expression levels and genomic variant calling. Another 
cloud computing pipeline for calculating differential gene expression in large RNA-seq 
datasets is Myrna [43]. Myrna uses bowtie [61] for short read alignment and R/bioconduc-
tor for quantification, normalization, and statistical testing. These tools are combined in an 
automatic, parallel pipeline that runs in the cloud, exploiting the availability of multiple 
computers and processors wherever possible. Stormbow [44] is a scalable, cost-effective, 
and open-source-based tool for large-scale RNA-seq data analysis. Its performance has 
been tested by applying it to analyze 178 RNA-seq samples in the cloud. In the test, it took 
6–8 h to process each RNA-seq sample with 100 million pair-ended reads in the m1.xlarge 
instance, and the average cost was only $3.50 per sample. BioVLAB-MMIA-NGS [51, 52] 
offers the integrated miRNA-mRNA analysis and can be used to identify the “many-to-
many” relationship between miRNAs and target genes with high accuracy. PeakRanger [48] 
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is a software  package for the analysis of ChIP-seq data. It can be run in a parallel cloud 
computing environment to obtain extremely high performance on large data sets. Unbiased 
NGS approaches enable comprehensive pathogen detection in the clinical microbiology 
laboratory [63] and have numerous applications for public health surveillance, outbreak 
investigation, and the diagnosis of infectious diseases. Sequence-based ultra rapid pathogen 
identification (SURPI™) [53] is a computational pipeline for pathogen identification from 
complex metagenomic NGS data generated.
4.4. Rainbow
Crossbow is a software tool that can detect SNPs in WGS data from a single subject; how-
ever, it has a number of limitations when applied to large-scale WGS projects. Rainbow [12] 
is a cloud-based software package that can assist in the automation of large-scale WGS data 
analyses. Rainbow was built upon Crossbow. By hiding the complexity of the Crossbow 
command-line options, Rainbow facilitates the application of Crossbow for large-scale WGS 
analysis in the cloud. Compared with Crossbow, the main improvements incorporated into 
Rainbow include the ability: (1) to handle BAM as well as FASTQ input files, (2) to split large 
sequence files for better load balance in downstream clusters, (3) to collect and track the run-
ning metrics of data processing and monitoring multiple Amazon EC2 instances, and (4) to 
merge SOAPsnp outputs from multiple individuals into a single file to facilitate downstream 
genome-wide association studies.
The workflow of Rainbow is shown in Figure 3. Multiple data drives are shipped to Amazon. 
After the BAM or FASTQ files have been uploaded to S3, large FASTQ files are split into 
smaller files in parallel. Then multiple clusters are launched in the cloud, with each clus-
ter processing a single sample. Crossbow is responsible for mapping reads to the reference 
sequence and for SNP calling. The SNPs for all samples are then combined by a Perl script. 
When the analysis is complete, the results can either be downloaded directly or exported via 
Amazon Export. We applied Rainbow to analyze the 44 subjects, with 0.55–1 billion pair-
ended 100 bp short reads per sample. The running environments were as follows. For step #1 
in Figure 3, we chose the Amazon m1.large instance, which has two CPUs, 7.5 GB memory, 
and two 420 GB instance drives. For Crossbow run, each compute cluster has 40 c1.xlarge 
nodes as recommended by the Crossbow developers. Each c1.xlarge node has 8 CPUs, 7 GB 
memory, and 1690 GB instance storage.
The performance of Rainbow is summarized in Figure 4. In a 320-CPU (=40 × 8) cluster, the 
alignment of billions of reads takes between 0.8 and 1.6 h. The linear relationship shown in 
Figure 4 indicates that the sequence data blocks in the Hadoop distributed file system (HDFS) 
are physically local to the nodes that processed them, which reduces virtual I/O delays. The 
SOAPsnp running time ranges from 1 to 1.8 h, which takes a little longer than the alignment. 
All EC2 instances and clusters are terminated immediately after the jobs are finished. On 
average, it costs less than 120 US dollars to analyze each subject, and the total cost for analyz-
ing those 44 subjects was 5800 US dollars, including data import. More important than the 
cost is the ability to scale Rainbow up or down, so that the analyses can be  accomplished 
in a  reasonably short amount time, regardless of sample size. No upfront investment in 
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Figure 3. The Rainbow pipeline. S3 centralizes data storage, including inputs, intermediate results, and outputs. 
Alignment and SNP call are performed by Crossbow in a cluster with multiple nodes.
Figure 4. Top panel: running time of bowtie alignment vs. the number of paired sequence reads. Bottom panel: running 
time of SOAPsnp vs. the number of paired mapped reads. Note: each cluster consists of 40 c1.xlarge instances (8 CPUs 
per c1.xlarge instance).
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 infrastructure is required and there is no additional administrative costs involved using 
Amazon cloud. Rainbow is a scalable, cost-effective, and open-source tool for large-scale 
WGS data analysis. It is available for third-party implementation and use, and can be down-
loaded from the Rainbow website.
In order to access the Rainbow cloud pipeline, the user must first set up an AWS account 
(http://aws.amazon.com/). Once registered, the user needs to sign up for Amazon EC2, 
S3, EMR, and SES services. The user can then start an instance based on the public AMI: 
ami-0f1f9866 in US-East (N. Virginia); or ami-b6bc89f3 in US-West (N. California). All 
required software is already preinstalled and configured in the AMI. Then, the user can 
connect to the instance and configure EC2, EMR, and S3cmd command-line tools. After 
a successful connection to the instance has been established, the user needs to prepare a 
sample manifest file in order to run Rainbow. A master manifest file is a plain text file to 
describe all subjects in a WGS project. Each subject has a corresponding entry in the mani-
fest file and each entry consists of three fields separated by spaces or tabs: (1) a unique 
identifier; (2) locations of the raw reads in S3; and (3) an output folder in S3. Each indi-
vidual step in the Rainbow workflow uses this same manifest file as input, thus all output 
files are named and stored consistently. After the creation of the manifest file, the user just 
needs to run a couple of command lines and all the analyses will be done automatically in 
the cloud.
Analyzing large datasets in the cloud is different from performing the same analysis in a local 
environment. When developing Rainbow, we have learned the following lessons.
• It is not trivial to move large datasets around within the cloud. Users should be prepared to 
handle network congestion or failures, never assuming data transfer is always successful. 
If data move fails, it is a good practice to wait a couple of minutes and then try to transfer 
data again. Repeat the “wait-and-transfer” cycle till data transfer is successful.
• Boot time should be taken into account when new resources are starting up. It is recom-
mended to give cloud providers 10–15 min grace period (waiting time) before attempting 
to use a newly requested resource, for instance, elastic block store (EBS).
• Cloud providers typically offer a variety of compute instances to choose from. To choose 
the best option, it is important to understand the bottleneck (CPU, I/O, or network) for the 
algorithm that is to be run.
• When large amounts of data are moved between cloud resources, it is essential to ensure 
that they are in the same location or data center.
• It is difficult to debug workflows in the cloud without heavy logging.
5. Cloud computing hurdles
Albeit relatively new, cloud computing holds great promise in effectively addressing big data 
storage and analysis problems in NGS data analysis. Despite the potential gains achieved, 
there are also several important issues that need to be addressed. Below, we present the main 
hurdles on the adoption of cloud computing.
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5.1. Big data transfer
To analyze the NGS data in the cloud, data have to be transferred across the wired network and 
uploaded onto AWS. The volume and complexity of NGS data have exponentially increased, 
giving rise to issues related to data analysis, management, and transfer to the cloud [64–66]. 
For example, WGS of 400 subjects at 30× coverage will generate approximately 100 TB raw 
sequence reads in FASTQ format. In the future, more and more sequencing projects would 
generate ultra-large volumes of biological data and thus require bioinformatics clouds for big 
data storage, sharing, and analysis. One of the most challenging issues of cloud computing is 
data transfer. Transferring vast amounts of biological data to the cloud is a significant bottle-
neck in cloud computing.
The speed of data transfer is usually slow and at present there are not many solutions available 
for moving the huge amount of data to cloud. Therefore, we need more efficient data transfer 
technologies in cloud computing. According to CloudHarmoy’s report on download speed 
relative to the year 2010 (http://blog.cloudharmony.com/2010/02/cloud-speed-test-results.
html), the download speed from Amazon AWS EC2 in North Virginia (U.S.) was 2.95 Mb/s, 
which corresponds to downloading a 10 GB file in 29,116 s (*8 h). Therefore, data transfer is a 
serious bottleneck in NGS data analysis on cloud service. To deal with the data transfer issue, 
Aspera (http://www.asperasoft.com/) has developed the fast and secure protocol (FASP) for 
data transfer with a speed of up to 5 GB/s. Ideally, using FASP, the user can download a 10 GB 
file in 17.2 s, which is a revolutionary improvement. But still it cannot transfer data at the TB 
scale. Alternatively, sequencing service providers such as BGI and Illumina offer a service in 
which they deliver a hard disk drive (HDD) containing the sequencing data. However, the 
shipping has limitations aside from the time taken up by travel, and once a package (of hard 
drives) is stamped and sealed, researchers cannot control when (and sometimes if) the parcel 
arrived or what condition it arrived. This service cannot guarantee safe transfer of data, since 
the HDD can get lost, stolen, or physical errors can occur.
5.2. Most bioinformatics tools are not cloud-aware
Most bioinformatics software tools are written for desktop (rather than cloud) applications 
and are therefore not provided as cloud-based web services accessible via the Web, making 
it infeasible to perform complex bioinformatics tasks in the cloud. For instance, bowtie [61] is 
one of the most popular mapping algorithms, but it requires that input files are stored on local 
disk when mapping reads and is not compatible with Amazon S3. Even if you run bowtie in 
an EC2 instance, the raw FASTQ files have to be fetched to an elastic block store (EBS) volume 
that is attached to the EC2 instance. In other words, bowtie does not have built-in support for 
S3. Spliced transcripts alignment to a reference (STAR) [67–69] is a popular RNA-seq mapper 
that performs highly accurate spliced sequence alignment at an ultrafast speed. However, it is 
not cloud-friendly either. Like bowtie, STAR does not take advantage of AWS cloud services, 
and cannot work with S3 either. Unfortunately, the majority of bioinformatics tools are devel-
oped without native support for cloud computing.
MapReduce [70, 71], developed by Google, is an easy-to-use and general-purpose parallel 
programming model that is suitable for large data set analysis on a commodity hardware 
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cluster. MapReduce is a software framework, written in Java, designed to run over a clus-
ter of machines in a distributed way. A MapReduce program is composed of a user-defined 
map function and a reduce function. When a program that is implemented with the map 
and reduce functions has been launched, the map function processes each key/value pair 
and produces a list of intermediate key/value pairs, while the reduce function aggregates 
all the intermediate values with the same keys. MapReduce is an important advancement in 
cloud computing because it can process huge data sets quickly and safely using commodity 
hardware.
Hadoop, comprised of MapReduce and the Hadoop distributed file system (HDFS), is based 
on a strategy of colocating data and processing to significantly accelerate computing perfor-
mance [60]. Hadoop allows for the distributed processing of large datasets across multiple 
computer nodes, supports big data scaling, and enables fault-tolerant parallel analysis. The 
Hadoop framework has been recently deemed as the most suitable method for handling bioin-
formatics data [70]. Unfortunately, many traditional bioinformatics tools and algorithms have 
to be redesigned and implemented in order to support and benefit from Hadoop MapReduce 
infrastructure. Even with the help of the corresponding developers, it will take a while for 
most bioinformatics tools currently available to add this feature.
Apache Spark™ (https://spark.apache.org/) is a fast and general engine for large-scale data 
processing, natively supported in Amazon EMR. Apache Spark supports a variety of lan-
guages, including Java, Scala, and Python, for developers to build applications. Hadoop and 
Apache Spark are both big data frameworks, but they do not really serve the same purposes. 
Hadoop is essentially a distributed data infrastructure. It distributes massive data collections 
across multiple nodes within a cluster of commodity servers, Spark, on the other hand, is a 
data-processing tool that operates on those distributed data collections; it does not do dis-
tributed storage. To study the utility of Apache Spark in the genomic context, SparkSeq was 
created [72]. It is a general-purpose, flexible, and easily extendable library for genomic cloud 
computing, and can be used to build genomic analysis pipelines in Scala and run them in 
an interactive way. Recently, SparkBWA [73] was introduced; a new tool that exploits Spark 
to boost the performance of one of the most widely adopted sequence aligner, the Burrows-
Wheeler Aligner (BWA). It is hoped more Apache Spark-based bioinformatics algorithms will 
be developed for large-scale genomic data analysis in the future.
5.3. Open clouds for bioinformatics
Currently, the largest cloud computing provider is Amazon, which provides commercial 
clouds for processing big data. Additionally, Google also provides a cloud platform to allow 
users to develop and host applications, and to store and analyze data. However, commercial 
clouds are not yet able to provide ample data and software for bioinformatics analysis. By 
placing public biological database and software into the cloud and delivering them as ser-
vices, data and software can be seamlessly and easily integrated into the cloud. AWS hosts a 
variety of public data sets for free access (https://aws.amazon.com/public-data-sets/). All pub-
lic datasets in AWS are delivered as services. Previously, large data sets, such as the mapping 
of the human genome, required hours or days to locate, download, customize, and analyze. 
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Now, anyone can access these data sets via the AWS centralized data repository from any 
Amazon EC2 instance or Amazon EMR cluster. Google Genomics also helps the life science 
community organize the world’s genomic data and make them accessible and useful.
In the era of big data, however, only a tiny amount of biological data is accessible in the cloud 
at present (only AWS, including GenBank [35], Ensembl [74], 1000 Genomes [20], etc.) and the 
vast majority of data are still deposited in conventional biological databases. It is difficult for 
commercial clouds to keep pace with the emerging needs from academic research, opening up 
the demand for specific open clouds for bioinformatics studies. Needless to say, open access 
and public availability of data and software are of great significance to biological science. To 
satisfy the need for big data storage, sharing, and analysis with lower cost and higher effi-
ciency, it is essential that a large number of biological data as well as a wide variety of bioin-
formatics tools should be publicly accessible in the cloud and delivered as services. Therefore, 
future efforts should be devoted to building open bioinformatics clouds for the bioinformatics 
community. GenomeSpace [75] is a cloud-based, cooperative community resource that cur-
rently supports the streamlined interaction of 20 bioinformatics tools and data resources. To 
facilitate integrative analysis by nonprogrammers, it offers a growing set of 'recipes', short 
workflows to guide investigators through high-utility analysis tasks. The potential benefits of 
open bioinformatics clouds include maximizing the scope for data sharing, easing large-scale 
data integration, and harnessing collective intelligence for knowledge discovery.
5.4. Security and privacy
The many characteristics of cloud computing have made the long-dreamed vision of “com-
puting as a utility” a reality. The cloud computing offers scalable and competitively priced 
computing resources for the analysis and storage of data from large-scale genomics studies, 
but it must also ensure that genetic data coming from human subjects are hosted in a context 
that is both secure and compliant with regulations [76]. When deciding whether to move the 
analyses into the cloud or not, potential cloud users need to weigh all the factors including 
system performance, service availability, cost, and most importantly, data security. Genomics 
data extracted from clinical samples are sensitive data and present unprecedented require-
ments of privacy and security [11, 77]. In general, there are concerns that genomics and clinical 
data managed through a cloud are susceptible to loss, leakage, theft, unauthorized access, and 
attacks. The centralized storage and shared tenancy of physical storage space means the cloud 
users are at higher risk of disclosure of their sensitive data to unwanted parties. A secure pro-
tection scheme will be necessary to protect the sensitive information from medical records. 
There is considerable amount of work to enforce data protection against security attacks.
However, the question of security in cloud computing is intrinsically complicated. Cloud 
computing is built on the top of existing architectures and techniques such as SaaS and distrib-
uted computing. When combining all the benefits of these architectures and techniques, cloud 
computing also inherits almost all of their security issues at various levels of the system stack. 
When cloud users move their applications from within their enterprise/organization bound-
ary into the open cloud, they will lose physical control over their data, and traditional security 
protection mechanisms such as firewalls are no longer applicable to cloud  applications. As a 
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result, cloud users have to heavily rely upon the service providers for data privacy and secu-
rity protection. In cloud computing, the data and applications from different customers reside 
on the same physical computing resources. This fact will inevitably bring forth more security 
risks in the sense that any intentional or inadvertent misbehavior by one cloud user would 
make other coresidences victims.
6. Conclusion
Pharmacogenomics is an important branch of genomics that studies the impact of SNP on 
drug response in patients, the toxicity or efficacy of a drug, and the development of diseases 
[78, 79]. Pharmacogenomics aims to improve drug therapy with respect to the patients’ geno-
type, to ensure maximum efficacy with minimal adverse effects, and is at the basis of the idea 
of “precision medicine” where drugs are chosen or optimized to meet the genetic profile of 
each patient. Thus, the presence (or the absence) of specific SNPs may be used as a clinical 
marker to predict drug effectiveness, and to foresee the drug responses of individuals with 
different SNPs. Precision medicine also opens up the possibility to treat diseases based on 
the genetic makeup of the patient. Identification of the genetic defect underlying early-onset 
diabetes is important for determining the specific diabetes subtype, providing personalized 
treatment. The study by Artuso et al. [14] has revealed that NGS provides a highly sensi-
tive method for identification of variants in a new-set of “driver genes” causing diabetes. 
NGS can be used to analyze the comprehensive landscape of genetic alterations, including 
known disease-causing gene fusions in transcripts, which brings new insights to study dis-
eases with a highly complex and heterogeneous genetic composition such as cancer [19]. 
Therefore, NGS facilitates precision medicine and changes the paradigm of cancer therapy, 
and holds expanded promise for its diagnostic, prognostic, and therapeutic applicability in 
various diseases.
The substantial decrease in the cost of NGS techniques in the past decade has dramatically 
reshaped the biomedical research and has led to its rapid adoption in biological research and 
drug development [3, 4]. Nowadays, massive amount of data, targeting a variety of biological 
questions, can be generated quickly using NGS platforms. These data range from the function 
and regulation of genes, the clinical diagnosis and treatment of diseases, to the omics profiling 
of individual patients for precision medicine. To better understand the association between 
SNPs and diseases, and to gain deeper insights into the relation between drug response and 
genetic variations, large-scale sequencing projects are continuously being initiated in research 
institutes and pharmaceutical companies. The availability of NGS and the genomics studies 
of large populations are producing an increasing amount of data. However, the storage, pre-
processing, and analysis of NGS data are becoming the main bottleneck in the analysis pipe-
line. With the exponential increase in volume and complexity of NGS data, cluster or high 
performance computing (HPC) systems are essential for the analysis of large amounts of NGS 
data. But the associated costs with the infrastructure itself and the maintenance personnel will 
likely be prohibitive for small institutions or laboratories, and even too much to swallow for 
big institutions and pharmaceutical companies.
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This chapter provides a useful perspective on cloud computing and helps researchers, who 
plan to analyze their NGS data on cloud services, to gain an understanding of the basic con-
cept. As discussed earlier, cloud computing drives down infrastructure costs both up-front 
and on an on-going basis. It offers many operational advantages, such as fast completion 
of massive computational projects and infrastructures can be set up in minutes rather than 
months. There are growing demands for cloud-based NGS data analysis, which constitutes a 
good alternative for researchers with little interest in investing in a cluster system. Cloud com-
puting is becoming a technology mature enough for its use in genomic researches. The use 
of large datasets, the demanding analysis algorithms, and the urgent need for computational 
resources, make large-scale sequencing projects an attractive test-case for cloud computing. 
It is likely that in the future, researchers will be able to analyze their NGS data on cloud ser-
vices for a cost low enough to eliminate the need to introduce clusters into their laboratories. 
However, we must emphasize that there are a number of open issues and problems associ-
ated with the use of cloud, such as privacy and security, especially when managing patients’ 
clinical data. Data transfer of large amounts of NGS data to the cloud remains a challenge and 
bottleneck in NGS data analysis. Furthermore, many traditional NGS tools are not designed 
to use in cloud environment, and thus cannot harness the benefits of cloud services. With 
the ever-increasing demand, commercial companies and bioinformaticians will develop more 
NGS analysis tools, using APIs offered by service providers, in the foreseeable future, making 
NGS data analysis in the cloud more efficient, friendly, and secure.
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